2022
medRxiv (2022).
2022
Wellcome Open Res (2022).
2022
BMJ, (2022).378,
2022
British Medical Journal, (2022).378,
2022
BMC medicine, (2022).20 1
Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform.
2022
BRITISH JOURNAL OF DERMATOLOGY, (2022).187,
2022
The Lancet Rheumatology, (2022).4 7
2022
Vaccine, (2022).40 32
2022
medRxiv (2022).
2022
PLoS Medicine, (2022).19 5